InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
54%
T+90 mean return
+6.4%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Goff Brian, EVP et Directeur Commercial. Insider active across 4 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 29 disclosures have been recorded. Split: 0 buy · 8 sells. Total volume traded: €1.6m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 2 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations29 total
9,200 sharesCommon StockSEC:0001193125-26-266236:0
8,500 shares0Common stockSEC:0001439222-26-000044:0
3,870 shares@ US$28.965.9% of flowCommon stockSEC:0001439222-26-000044:1
18,000 shares0Common stockSEC:0001439222-26-000044:2
8,267 shares@ US$28.9612.6% of flowCommon stockSEC:0001439222-26-000044:3
13,000 shares0Common stockSEC:0001439222-26-000044:4
5,918 shares@ US$28.969.0% of flowCommon stockSEC:0001439222-26-000044:5
22,691 shares0Common stockSEC:0001439222-25-000093:0
11,085 shares@ US$36.6721.6% of flowCommon stockSEC:0001439222-25-000093:1
8,500 shares0Common stockSEC:0001439222-25-000015:0
4,153 shares@ US$35.548.8% of flowCommon stockSEC:0001439222-25-000015:1
18,000 shares0Common stockSEC:0001439222-25-000015:2
8,794 shares@ US$35.5418.6% of flowCommon stockSEC:0001439222-25-000015:3
22,691 shares0Common stockSEC:0001439222-24-000123:0
15,409 shares0Common StockSEC:0000950170-24-074383:0
25,527 shares0Common stockSEC:0001439222-24-000073:0
8,500 shares0Common stockSEC:0001439222-24-000048:0
4,156 shares@ US$32.577.7% of flowCommon stockSEC:0001439222-24-000048:1
17,018 shares0Common stockSEC:0001439222-24-000014:0
12,066 shares@ US$22.9915.7% of flowCommon stockSEC:0001439222-24-000010:1
25,527 shares0Common stockSEC:0001439222-24-000010:0
22,691 shares0Common stockSEC:0001439222-23-000123:0
25,528 shares0Common stockSEC:0001439222-23-000103:0
150,832 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000069
150,832 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000069:0
25 of 29 declarations
About Goff Brian
Brian Goff is EVP & Chief Commercial Officer at Alexion Pharmaceuticals, Inc. He is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential for leading growth initiatives.
